Literature DB >> 25361198

High prevalence of genotype 6E (putative serotype 6E) among noninvasive/colonization isolates of Streptococcus pneumoniae in northern Japan.

Mitsuyo Kawaguchiya1, Noriko Urushibara, Nobumichi Kobayashi.   

Abstract

Serogroup 6 of Streptococcus pneumoniae contains four established serotypes (6A-6D). Recently, putative serotype 6E (genotype 6E) was proposed as a novel type, which is cross-reactive with 6B-specific antiserum, but its capsular polysaccharide synthesis (cps) locus is genetically distinct from those of serotypes 6A and 6B. In the present study, prevalence of genotype 6E was analyzed by a newly designed multiplex polymerase chain reaction (PCR) for noninvasive or colonizing S. pneumoniae isolates in northern Japan assigned to serogroup 6 in our previous study by the sequential multiplex PCR developed by Pai et al. Among the isolates previously assigned to 6A and 6B, 2.2% (1/45) and 77.3% (140/181) of isolates, respectively, were revealed to have cps genes of genotype 6E. Eight 6E isolates selected for further analysis were found to have identical or highly similar sequences of cps genes (wzg, wzh, wze, wciN, wciP, and wzy) to those of strains previously reported as putative serotype 6E, and all the isolates were classified into sequence type 90 (ST90). Reanalysis of genetic traits on penicillin and macrolide resistance clarified significantly higher rates of three pbp mutations (gPRSP) and ermB in genotype 6E than in serotypes 6A and 6B. These findings suggested a need for detection of genotype 6E in the surveillance of S. pneumoniae serotypes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25361198     DOI: 10.1089/mdr.2014.0181

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  8 in total

1.  Pneumococcus with the "6E" cps Locus Produces Serotype 6B Capsular Polysaccharide.

Authors:  Robert L Burton; K Aaron Geno; Jamil S Saad; Moon H Nahm
Journal:  J Clin Microbiol       Date:  2016-01-27       Impact factor: 5.948

2.  Genomics Reveals the Worldwide Distribution of Multidrug-Resistant Serotype 6E Pneumococci.

Authors:  Andries J van Tonder; James E Bray; Lucy Roalfe; Rebecca White; Marta Zancolli; Sigríður J Quirk; Gunnsteinn Haraldsson; Keith A Jolley; Martin C J Maiden; Stephen D Bentley; Ásgeir Haraldsson; Helga Erlendsdóttir; Karl G Kristinsson; David Goldblatt; Angela B Brueggemann
Journal:  J Clin Microbiol       Date:  2015-05-13       Impact factor: 5.948

3.  Long-Term Epidemiology of Streptococcus pneumoniae Serogroup 6 in a Region of Southern Europe with Special Reference to Serotype 6E.

Authors:  José M Marimón; María Ercibengoa; Esther Tamayo; Marta Alonso; Emilio Pérez-Trallero
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

4.  Emerging non-PCV13 serotypes of noninvasive Streptococcus pneumoniae with macrolide resistance genes in northern Japan.

Authors:  M Kawaguchiya; N Urushibara; M S Aung; S Morimoto; M Ito; K Kudo; A Sumi; N Kobayashi
Journal:  New Microbes New Infect       Date:  2015-11-11

5.  Clonal and serotype dynamics of serogroup 6 isolates causing invasive pneumococcal disease in Portugal: 1999-2012.

Authors:  Jorge Diamantino-Miranda; Sandra Isabel Aguiar; João André Carriço; José Melo-Cristino; Mário Ramirez
Journal:  PLoS One       Date:  2017-02-02       Impact factor: 3.240

6.  Comparison of Serotype Prevalence of Pneumococci Isolated from Middle Ear, Lower Respiratory Tract and Invasive Disease Prior to Vaccination in Iceland.

Authors:  Martha Á Hjálmarsdóttir; Sigríður Júlía Quirk; Gunnsteinn Haraldsson; Helga Erlendsdóttir; Ásgeir Haraldsson; Karl G Kristinsson
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

7.  Effect of Vaccination on Pneumococci Isolated from the Nasopharynx of Healthy Children and the Middle Ear of Children with Otitis Media in Iceland.

Authors:  Sigríður J Quirk; Gunnsteinn Haraldsson; Helga Erlendsdóttir; Martha Á Hjálmarsdóttir; Andries J van Tonder; Birgir Hrafnkelsson; Samuel Sigurdsson; Stephen D Bentley; Ásgeir Haraldsson; Angela B Brueggemann; Karl G Kristinsson
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

8.  Reduction of antimicrobial resistant pneumococci seven years after introduction of pneumococcal vaccine in Iceland.

Authors:  Martha Á Hjálmarsdóttir; Gunnsteinn Haraldsson; Sigríður Júlía Quirk; Ásgeir Haraldsson; Helga Erlendsdóttir; Karl G Kristinsson
Journal:  PLoS One       Date:  2020-03-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.